“Akagizeebway”, yes, phonetically. It's quite long.
In response to the question, I think we need to recognize also that we have made tremendous progress with regard to access to HIV treatment, but the number of people who are still in need greatly outreaches the people who have actually accessed treatment. So if you're looking at the figures of people who are dying daily from HIV, TB, and malaria, they're shocking, but it would be a lot worse in absence of the progress that has been made.
I agree that access to medicines in general is a challenge in most countries in the region. Underinvestment in health is a challenge, and it really underpins a lot of these problems with getting medicines to people who need them the most. But I think we need to recognize that this doesn't take away from the need to ensure that medicines are affordable.
What we've seen also with the funding crisis that I mentioned earlier is that where in the past people were guaranteed they would get the HIV treatment paid for by government, because of funding constraints now, that guarantee does not exist in many places. You are finding people having to pay for ARVs out of pocket. In that case, the price of the drug on the shelf in the pharmacy really is the most determining factor in whether someone accesses the treatment or not.
So just in terms of crucial...rolling out HIV treatment has been one of the most vital ways that we've strengthened supply to management systems in the region, and additionally, the platform that HIV activism has created has had ripple effects across the drug management system. We are seeing prosecutions happening, we're seeing reorganization of organizational structures in countries like Swaziland, recently this week, for example, to improve the way the drugs flow. That is a direct result of HIV treatment advocacy. So instead of trying to say that we can....
Okay, I'll leave it there.